Glomerulopatías

  1. Puyol, D. Rodríguez
  2. Miguel, P. Martínez
  3. de Arriba de la Fuente, G.
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2019

Series: 12

Issue: 80

Pages: 4711-4716

Type: Article

DOI: HTTPS://DOI.ORG/10.1016/J.MED.2019.05.028 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

The term glomerulopathy, also known as glomerulonephritis, defines a group of disorders characterized by the impairment of glomerular filtration membrane appearing, cellular components and macromolecules in urine and accompanied by variable deterioration of purifying function of kidney. It encompasses an heterogeneous group of nosological entities, showing quite common clinical patterns, highlighting among them nephritic and nephrotic syndrome, recurrent macroscopic hematuria and changes in urinary sediment. Although glomerular filtration rate can be normal, in many cases renal insufficiency with a variable temporal course develops. Pathological studies have developed a key role in their operative classification, allowing both the clinical course typing as well as to define their prognosis and treatment.

Bibliographic References

  • Aljama P, Arias M, Caramelo C, Egido J, Lamas S. Nefropatías glomerulares. Hernando. Nefrología clínica. 3ª ed. Madrid: Editorial Panamericana; 2009. p. 299-398.
  • Appel GB, Radhakrishnan J, D’Agati V. Enfermedades glomerulares secundarias. Brenner y Rector. El riñón. 10ª ed. Barcelona: Elsevier, España; 2018. p. 1091-160.
  • Couser WG. Basic and translational concepts of immune mediated glomerular diseases. J Am Soc Nephrol. 2012;23(3):381-99.
  • Couser WG, Johnson RJ. The etiology of glomerulonephritis: roles of infection and autoimmunity. Kidney Int. 2014;86(5):905-14.
  • Fogo A, Kashgarian M. Enfermedades glomerulares. Atlas diagnóstico de patología renal. 3ª ed. Barcelona: Elsevier; 2018. p. 19-81.
  • Haas M, Rastaldi MP, Fervenza FC. Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification. Kidney Int. 2014;85(4):779-93.
  • Hertig A, Rondeau E. Role of the coagulation/fibrinolysis system in fibrin associated glomerular injury. J Am Soc Nephrol. 2004;15(4):844-53.
  • Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006;69(2):213-7.
  • Pendergraft WF, Nachman PH, Jennette JC, Falk RJ. Enfermedades glomerulares primarias. Brenner y Rector. El ri-ñón. 10ª ed. Barcelona: Elsevier; 2018. p. 1012-90
  • Pickering MC, D’Agati VD, Nester CM, Smith RJ, Haas M, Appel GB. C3 glomerulopathy: consensus report. Kidney Int. 2013;84(6):1079-89.
  • Rippe B. What is the role of albumin in proteinuric glomerulopathies? Nephrol Dial Transplant. 2004;19(1):1-5.
  • Weening JJ, Ronco P, Remuzzi G. Advances in the pathology of glomerular diseases. Contrib Nephrol. 2013;181:12-21.
  • Yokoyama H, Wada T, Furuichi K. Chemokines in renal fibrosis. Contrib Nephrol. 2003;139:66-89.
Data source: Dialnet